{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:19:53Z","timestamp":1782602393533,"version":"3.54.5"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.2169\/internalmedicine.2083-18","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T22:34:48Z","timestamp":1547073288000},"page":"1287-1293","source":"Crossref","is-referenced-by-count":16,"title":["In-stent Massive Thrombi Formation During Primary Percutaneous Coronary Intervention in a Patient with Acute Myocardial Infarction Complicated with Essential Thrombocythemia"],"prefix":"10.2169","volume":"58","author":[{"given":"Keisuke","family":"Shoji","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yanishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Kyoto Daiichi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Zen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hyogo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Kyoto Daiichi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Shirayama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoaki","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Kyoto Daiichi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Dan K, Yamada T, Kimura Y, et al. Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the Japanese Elderly Leukemia and Lymphoma Study Group. Int J Hematol 83: 443-449, 2006."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rossi C, Randi ML, Zerbinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med 244: 49-53, 1998.","DOI":"10.1046\/j.1365-2796.1998.00314.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pande S, Joshi R, Pande R. Essential thrombocythemia in a young man treated for myocardial infarction. BMJ Case Reports 3: 2010  (Epub ahead of print).","DOI":"10.1136\/bcr.09.2009.2234"},{"key":"4","unstructured":"4. Bhat T, Ahmed M, Baydoun H, Ghandour Z, Bhat A, McCord D. Acute ST-segment elevation myocardial infarction in a young patient with essential thrombocythemia: a case with long-term follow-up report. J Blood Med 5: 123-127, 2014."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chang H, Shim CY, Cheong JW, et al. Coronary artery intervention after cytostatics treatment in unstable angina patient with essential thrombocythemia. A case report and literature review. Korean J Intern Med 21: 146-149, 2006.","DOI":"10.3904\/kjim.2006.21.2.146"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Doesch C, Kr\u00e4mer B, Geisler T, et al. Challenges in the treatment of patients with essential thrombocythemia and acute coronary syndrome. J Thromb Thrombolysis 25: 193-197, 2008.","DOI":"10.1007\/s11239-007-0082-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tortorella G, Calzolari M, Tieghi A, Mui\u00e0 N, Piccin A, Gugliotta L. Acute coronary syndrome (ACS) in patients with essential thrombocytemia (ET). What is the best treatment? Int J Cradiol 203: 225-227, 2016.","DOI":"10.1016\/j.ijcard.2015.10.043"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Watanabe T, Fujinaga H, Ikeda Y. Acute myocardial infarction in a patient with essential thrombocythemia who underwent successful stenting-a case report. Angiology 56: 771-774, 2005.","DOI":"10.1177\/000331970505600616"},{"key":"9","unstructured":"9. Mizuta E, Takeda S, Sasaki N, et al. Acute myocardial infarction in a patient with essential thrombocythemia: successful treatment with percutaneous transluminal coronary recanalization. Circ J 69: 1000-1002, 2005."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Daya SK, Gowda RM, Landis WA, Khan IA. Essential thrombocythemia-related acute ST-segment elevation myocardial infarction. A case report and literature review. Angiology 55: 319-323, 2004.","DOI":"10.1177\/000331970405500312"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Turgut T, Harjai KJ, Edupuganti R, et al. Acute coronary occlusion and in-stent thrombosis in a patient with essential thrombocythemia. Cathet Cardiovasc Diagn 45: 428-433, 1998.","DOI":"10.1002\/(SICI)1097-0304(199812)45:4<428::AID-CCD19>3.0.CO;2-E"},{"key":"12","unstructured":"12. Isilak Z, Tezcan M, Atalay M, Kardesoglu E. Acute myocardial infarction and sub-acute stent thrombosis associated with occult essential thrombocythemia. Chin Med J (Engl) 127: 3512-3513, 2014."},{"key":"13","unstructured":"13. Tefferi A, Barbui T. Essential thrombocythemia and polycythemia vera: focus on clinical practice. Mayo Clin Proc 90: 1283-1293, 2015."},{"key":"14","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood-2016-05-643346","volume":"128","author":"E Rumi","year":"2016","unstructured":"14. Rumi E, Cazzola M. How I treat essential thrombocythemia. Blood 128: 2403-2414, 2016.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357: 2001-2015, 2007.","DOI":"10.1056\/NEJMoa0706482"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361: 1045-1057, 2009.","DOI":"10.1056\/NEJMoa0904327"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Motovska Z, Hlinomaz O, Miklik R, et al. Prasugrel versus ticagrelor in patients with acute myocardial infarction treated with primary percutaneous coronary intervention multicenter randomized PRAGUE-18 study. Circulation 134: 1603-1612, 2016.","DOI":"10.1161\/CIRCULATIONAHA.116.024823"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kumagai N, Mitsutake R, Miura S, et al. Acute coronary syndrome associated with essential thrombocythemia. J Cardiol 54: 485-489, 2009.","DOI":"10.1016\/j.jjcc.2009.03.001"},{"key":"19","unstructured":"19. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 39: 213-260, 2018."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347: 969-974, 2002.","DOI":"10.1056\/NEJMoa020496"},{"key":"21","unstructured":"21. Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stale cardiovascular disease. N Engl J Med 377: 1319-1330, 2017."},{"key":"22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.CIR.86.1.131","volume":"86","author":"FW Bar","year":"1992","unstructured":"22. Bar FW, Verheugt FW, Col J, et al. Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation 86: 131-137, 1992.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","volume":"89","author":"The Thrombolysis in Myocardial Ischemia (TIMI) III B investigators null","year":"1994","unstructured":"23. The Thrombolysis in Myocardial Ischemia (TIMI) III B investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction. Results of TIMI IIIB trial. Circulation 89: 1545-1556, 1994.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nakagawa Y, Nobuyoshi M, Yamaguchi T, et al. Efficacy of abciximab for patients undergoing balloon angioplasty data from Japanese Evaluation of c7E3 Fab for Elective and Primary PCI Organization in Randomized Trial (JEPPORT). Circ J 73: 145-151, 2009.","DOI":"10.1253\/circj.CJ-08-0560"},{"key":"25","unstructured":"25. Koduganti SC, Shankar SJ. Systemic thrombolytic therapy for earlt coronary stent thrombosis. Indian Heart J 58: 245-248, 2006."},{"key":"26","unstructured":"26. Silverstein MN, Petitt RM, Solberg LA Jr, Fleming JS, Knight RC, Schacter LP. Anagrelide: a new drug for treating thrombocytosis. N Eng J Med 318: 1292, 1988."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Harrison CN, Bareford D, Butt N, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol 149: 352-375, 2010.","DOI":"10.1111\/j.1365-2141.2010.08122.x"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Fujimura M, Akaike M, Kato M, et al. Aggressive antiplatelet therapy before coronary stent implantation in acute coronary syndrome with essential thrombocythemia-a case report. Angiology 54: 485-490, 2003.","DOI":"10.1177\/000331970305400414"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/9\/58_2083-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T03:38:26Z","timestamp":1556941106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/9\/58_2083-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2083-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}